XML 21 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common stock
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive income (loss)
Accumulated other comprehensive income (loss)
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2019     23,890,855        
Beginning balance at Dec. 31, 2019 $ 679,723 $ (3,740) $ 300,729 $ 374,673 $ (3,740) $ 4,321 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 79,990     79,990      
Share-based compensation expense 2,693   $ 2,693        
Common stock issued (in shares)     140,386        
Common stock issued - Stock grants 782   $ 782        
Other comprehensive income (loss) 31,036         31,036  
Dividends declared ($1.40 per share) (13,865)     (13,865)      
Common stock repurchased (in shares)     (2,234,337)        
Common stock repurchased (58,869)   $ (25,699) (33,170)      
Ending balance (in shares) at Dec. 31, 2020     21,796,904        
Ending balance at Dec. 31, 2020 717,750   $ 278,505 403,888   35,357  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 115,422     115,422      
Share-based compensation expense 3,398   $ 3,398        
Common stock issued (in shares)     260,267        
Common stock issued - Stock grants 2,418   $ 2,418        
Other comprehensive income (loss) (14,217)         (14,217)  
Dividends declared ($1.40 per share) (21,338)     (21,338)      
Common stock repurchased (in shares)     (1,971,835)        
Common stock repurchased $ (88,094)   $ (34,465) (53,629)      
Ending balance (in shares) at Dec. 31, 2021 20,085,336   20,085,336        
Ending balance at Dec. 31, 2021 $ 715,339   $ 249,856 444,343   21,140  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 66,540     66,540      
Share-based compensation expense 4,106   $ 4,106        
Common stock issued (in shares)     143,369        
Common stock issued - Stock grants 0   $ 0        
Other comprehensive income (loss) (120,670)         (120,670)  
Dividends declared ($1.40 per share) (26,847)     (26,847)      
Common stock repurchased (in shares)     (1,498,325)        
Common stock repurchased $ (76,321)   $ (27,370) (48,951)      
Ending balance (in shares) at Dec. 31, 2022 18,730,380   18,730,380        
Ending balance at Dec. 31, 2022 $ 562,147   $ 226,592 $ 435,085   $ (99,530)